(S)-2-(3-(3-Aminopyrrolidin-1-carbonyl)-4,11-dihydroxy-2-methyl-5,10-dioxo-1H-naphtho[2,3-f]indol-1-yl)acetic acid

ID: ALA4792926

PubChem CID: 162671139

Max Phase: Preclinical

Molecular Formula: C24H21N3O7

Molecular Weight: 463.45

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1c(C(=O)N2CC[C@H](N)C2)c2c(O)c3c(c(O)c2n1CC(=O)O)C(=O)c1ccccc1C3=O

Standard InChI:  InChI=1S/C24H21N3O7/c1-10-15(24(34)26-7-6-11(25)8-26)16-19(27(10)9-14(28)29)23(33)18-17(22(16)32)20(30)12-4-2-3-5-13(12)21(18)31/h2-5,11,32-33H,6-9,25H2,1H3,(H,28,29)/t11-/m0/s1

Standard InChI Key:  NGNZVIHZKUWTCE-NSHDSACASA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    2.0663  -18.4734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0652  -19.2930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7732  -19.7019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7714  -18.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4801  -18.4698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4789  -19.2950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1890  -19.7064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1913  -18.0560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9060  -18.4719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9047  -19.2930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6140  -19.7028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6125  -18.0624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3224  -18.4685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3228  -19.2903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1044  -19.5439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5872  -18.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1038  -18.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1914  -17.2388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1884  -20.5236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6102  -17.2452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6153  -20.5200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3560  -17.4370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1552  -17.2667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8089  -16.8299    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4044  -18.8784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7613  -17.8082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4689  -17.3993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2986  -16.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4858  -16.5151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2156  -17.7313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3573  -20.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1567  -20.4906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4095  -21.2677    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7032  -19.8831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  2  0
 12  9  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
  8 18  2  0
  7 19  2  0
 12 20  1  0
 11 21  1  0
 17 22  1  0
 22 23  1  0
 22 24  2  0
 16 25  1  0
 23 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 23  1  0
 27 30  1  6
 15 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4792926

    ---

Associated Targets(Human)

CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.45Molecular Weight (Monoisotopic): 463.1380AlogP: 1.39#Rotatable Bonds: 3
Polar Surface Area: 163.16Molecular Species: ZWITTERIONHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 2.90CX Basic pKa: 8.99CX LogP: -0.21CX LogD: -0.40
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -0.25

References

1. Tikhomirov AS,Litvinova VA,Andreeva DV,Tsvetkov VB,Dezhenkova LG,Volodina YL,Kaluzhny DN,Treshalin ID,Schols D,Ramonova AA,Moisenovich MM,Shtil AA,Shchekotikhin AE.  (2020)  Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.,  199  [PMID:32428792] [10.1016/j.ejmech.2020.112294]

Source